INNOVATION
Innovation
Innovation is at the core of everything we do
Our founders bring decades of academic and commercial research leadership to the development of advanced ocular research technologies. By combining deep scientific knowledge with agile laboratory operations, ORT continuously advances new methods that enhance accuracy, speed, and experimental relevance.
- Ex Vivo Physiological Testing
- Globe Perfusion Platform
- Partnerships & SBIR/STTR Programs
Through strategic collaborations with eye banks, academic institutions, and pharmaceutical partners, ORT is building next-generation research platforms that advance both basic science and clinical discovery.
Ocular Tissue Biobanking
Creation of disease-specific human eye tissue slide sets to accelerate large-scale research studies.
Physiological Globe Perfusion
Advanced ex vivo models that preserve living human eye function for drug development and testing.
Custom Research Tools
Development of specialized reagents, protocols, and preservation systems designed specifically for ocular tissues.
Innovation
Ex Vivo Physiological Testing
(In Development)
ORT is developing advanced ex vivo human ocular testing platforms that preserve physiological function outside the body, providing researchers with highly predictive experimental models.
This platform enables real-time evaluation of drug candidates in living human eye tissue, offering insights that far exceed traditional cell culture or animal models.
Maintains native human tissue architecture and physiology
Produces more clinically predictive results
Reduces costly late-stage drug development failures
Accelerates candidate selection for clinical trials
“Innovative science requires the best in research partnerships”
Karen B. King, PhD
- Founder and Chief Executive Officer
Innovation
Globe Perfusion Platform
ORT’s proprietary human globe perfusion system maintains post-mortem donor eyes in a physiologically viable state for the duration of experimental testing.
Developed and led by Dr. Ammar, one of the few scientists globally with this specialized expertise, this platform allows pharmaceutical developers to test drug candidates under highly realistic biological conditions.
Sustains live ocular physiology
Enables precise compound delivery
Supports functional measurements
Provides unmatched translational relevance
This platform represents a significant advancement in pre-clinical ophthalmic research and enables deeper understanding of therapeutic effects before human clinical trials.
Innovation
Partnerships & SBIR/STTR Programs
ORT actively pursues strategic partnerships, government-funded innovation programs, and collaborative research initiatives to expand the reach and impact of its technologies.
We participate in Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs, collaborating with academic institutions, pharmaceutical developers, and research organizations to accelerate innovation and bring new ophthalmic technologies to market.
Translational
research
Advanced imaging technologies
Drug discovery platform development
Tissue engineering and organ culture systems
Through these partnerships, ORT extends its innovation ecosystem beyond its own laboratory, fostering breakthroughs that advance vision science worldwide.
Collaborate With Experts
Schedule a consultation with our team.